Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Journal of Market Access & Health Policy|March 27, 2025
Ensuring the Efficiency and Effectiveness of Joint Clinical Assessment in National HTA Decision-Making: Insights from the 2024 CIRS Multi-Stakeholder WorkshopTing Wang, Neil McAuslane
Therapeutic Innovation & Regulatory Science|August 2, 2025
Enhancing Development Strategies Through Early Scientific Advice from HTA Agencies-Experiences, Expectations and Best Practices from Health Technology DevelopersTing Wang, Neil McAuslane
Pharmaceutical Medicine|February 4, 2021
The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested SolutionsMagdalena Bujar, Neil McAuslane, Lawrence Liberti
Clinical Pharmacology and Therapeutics|November 26, 2018
The Confluence of Accelerated Regulatory and Health Technology Assessment Access PathwaysNeil McAuslane, Lawrence Liberti, Patricia Connelly
International Journal of Technology Assessment in Health Care|July 20, 2017
A DECADE OF HEALTH TECHNOLOGY ASSESSMENT IN POLANDIga Lipska, Neil McAuslane, Hubert Leufkens, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Quality of Regulatory Decision-Making Practices: Issues Facing Companies and AgenciesMagdalena Bujar, Neil McAuslane, Sam Salek, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
The Benefit-Risk Assessment of Medicines: Experience of a Consortium of Medium-Sized Regulatory AuthoritiesNeil McAuslane, James Leong, Lawrence Liberti, et al.
Pharmacoepidemiology and Drug Safety|June 7, 2013
Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectivesJames Leong, Neil McAuslane, Stuart Walker, et al.
Frontiers in Pharmacology|February 8, 2019
The Reliability and Relevance of a Quality of Decision Making Instrument, Quality of Decision-Making Orientation Scheme (QoDoS), for Use During the Lifecycle of MedicinesMagdalena Bujar, Neil McAuslane, Stuart Walker, et al.
International Journal of Health Policy and Management|July 3, 2020
A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of MedicinesMagdalena Bujar, Neil McAuslane, Stuart Walker, et al.
Pageof 5